Neonc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.58 | $0 | -$5M |
| 2026 Q1 | -0.38 | $0 | -$7M |
| 2025 Q4 | -0.81 | $0 | -$4M |
| 2025 Q3 | -0.45 | $0 | -$6M |
| 2025 Q2 | -0.30 | $0 | -$5M |
| 2025 Q1 | -2.10 | $39,990 | -$6M |